Q2:23 Thematic Earnings Roundup

Q2:23 Thematic Earnings Roundup

This earnings season has provided us with insights into how various publicly traded healthcare companies are navigating the current landscape. Let’s delve into the trends and outcomes that defined the second quarter of 2023. The Home Health & Hospice Market: The Erosion of Medicare Fee-For-Service The Home Health & Hospice (HH&H) market has been volatile of late, with companies like Amedisys Inc. (NASDAQ: AMED) reporting a significant shortfall in earnings and a decline in revenue compared to the same period last year. Amedisys reported a financial loss in the second quarter of $80.3 million, after reporting a profit in the same 2022 period. A significant portion of this... Read More »
Humana’s CenterWell Home Health Acquires Trilogy Home Health

Humana’s CenterWell Home Health Acquires Trilogy Home Health

CenterWell Home Health, a subsidiary of Humana Inc., has agreed to acquire Trilogy Home Health in Florida. According to data captured in the LevinPro HC database, this acquisition represents the 29th Home Health & Hospice (HH&H) transaction of 2023. The acquisition will expand CenterWell Home Health’s presence in Florida. Financial terms of the deal were not disclosed. Based in West Palm Beach, Trilogy Home Health has 11 locations across Florida. The company provides home health care, personal care and care coordination services. CenterWell Home Health provides home health services to more than 350,000 patients each year via its 350-plus locations across 38 states. CenterWell... Read More »
The Managed Care Earnings Round-Up

The Managed Care Earnings Round-Up

Some of the largest Managed Care providers in the world have announced their earnings for 2022, and the results are looking promising for the Managed Care space. Humana Inc., Centene Corporation and Cigna Corp. all achieved positive operating and financial results for 2022, with some even surpassing their expectations for the year. However, M&A within the Managed Care sector slowed in 2022, with just 43 transactions announced, a 10.4% decrease from 2021 when 48 deals were announced. This decline is the result of a shift in these company’s growth strategy as they focus on cleaning up their portfolios through divestments. Humana Inc. (NYSE:HUM) Humana reported strong operating and... Read More »
Humana Takes Full Ownership of Kindred at Home

Humana Takes Full Ownership of Kindred at Home

One of the largest healthcare insurance companies in the United States is taking complete ownership of one of the largest home health providers. Humana Inc. (NYSE: HUM) has acquired the remaining 60% stake in Kindred at Home that it did not own from both TPG Capital and Welsh, Carson, Anderson & Stowe (WCAS). The 60% stake, including debt, is valued at $5.7 billion, giving Kindred at Home a total equity value of $8.1 billion, but the pricing is a little more complicated than, at least according to Humana.  Kindred at Home (KAH) employs approximately 43,000 caregivers providing home health, hospice, and community care services to over 550,000 patients annually. The company has locations... Read More »
Humana Doubles Down on Hospice Services

Humana Doubles Down on Hospice Services

Humana Inc. (NYSE: HUM) is moving more deeply into hospice care with its recent announcement that it will acquire Philadelphia-based Enclara Healthcare from Consonance Capital Partners and Enclara management. Enclara is one of the largest hospice and pharmacy benefit management (PBM) providers in the country, serving 450 hospice providers and 97,000 hospice patients daily. This deal includes mail-order pharmacy Enclara Pharmacia, specialty PBM GuidantRx and pharmacy Avanti Health Care Services. Enclara’s palliative care provider, Turn-Key Health, is not included. Consonance first invested in Enclara in 2014 and added ExcelleRx, PGM Holdings and Avanti Health Care Services in the... Read More »